The Pharma Files: What Have you Missed?
As you probably know, Evaluate has an incredibly rich and comprehensive set of data and insight about the pharma market. This means we’re able to produce some really valuable reports, webinars and articles that provide insight around the most exciting areas of the industry. And we create rather a lot of them, which can make […]
Is it Time to Rethink Orphan Drugs?
If you follow Evaluate’s regular white papers and blogs, you may be familiar with our annual report that investigates the state of the orphan drug market. I’ve been involved in analyzing that data for the past three years, and have just finished the process for this year’s report which will be published soon. One of […]
How Pharma Professionals Rate Our Forecasting Training
Formal training is essential for stakeholder teams looking to enhance their forecasting expertise. By deepening their understanding of fundamental principles, methodologies, and process steps, teams can approach forecasting with greater confidence and ensure they are applying best practices effectively. However, learning should not be a passive process. We believe self-assessment is a powerful tool for […]
Three Things we Learned in our Long-Range Planning Webinar
How’s your long-range planning going? If you’re tasked with the forecasting processes for a pharma or biotech company, you may be in the midst of this annual cycle at the moment. Long-range planning (or LRP as the cool forecasters call it) provides a really important guide to company performance over five to 10 years. Like […]
Three Things we Learned in our 2025 Preview Webinar
The first Evaluate webinar of the year is in the bag. Based on our 2025 Preview report, this session brought together three of our industry experts to discuss what the year ahead might hold for pharma. They may not have had a crystal ball, but they had plenty of detailed data and insight which is […]
What Will 2025 Hold for Pharma?
Once again, the pharma industry starts a new year with hopes of a recovery. Will 2025 finally see a return of IPOs? Of mega-mergers? Of huge rounds of investment? Perhaps, but more likely this year will simply be a few steps in the right direction. There is still a great deal of uncertainty, particularly around […]
Epidemiology forecasting and the impact of data sources on accuracy
The relationship between epidemiology forecasting and data sources is a complex one. Generating accurate forecasts relies heavily on data, and factors such as real-world data and artificial intelligence (AI) have an increasing impact. Factors affecting forecast quality and accuracy There are a few factors that contribute to the accuracy of epidemiological forecasts. Firstly, the […]
Three Things we Learned in our “Taking the Pharma Industry Pulse” Webinar
One of the great things about working in the pharma industry is the opportunity to listen to very clever people talking about fascinating topics and the latest trends in the market. Events like BIO-Europe are brilliant for this, and there is always plenty to unpack after the panels, keynotes and fireside chats have ended. Our […]
Analogue forecasting: the power of the past to predict the future
Launching a first-in-class drug is high on the wish list of most pharma companies, but achieving that goal is not without its challenges. While patient demand for innovative therapies will always be high, modelling their impact on the treatment landscape is an uncertain business and the stakes are too high to rely on little more […]
Join the Discussion: Dealmaking, Innovation and Geopolitics in Pharma
BIO-Europe took place last week in Stockholm. It’s one of the last big biopharma events of the year and a great time to take stock of where the industry stands as the new year approaches. I was at the convention, taking part in a fireside chat to discuss global innovation trends. Also featuring on the […]
